|
- Clinical Trial Calendar, Clinical Trials - RTTNews
Get the latest information on Clinical Trials, FDA Drug Approvals, FDA Calendar, FDA Events and more on RTTNews
- Phase II Clinical Trials - BioSpace
Korro Bio is moving back to square one as a preclinical biotech after the failure of KRRO-110 in alpha-1 antitrypsin deficiency The company’s stock is down 80% on all the news
- Clinical Trial News | BioPharma Dive
The latest clinical trial news for biotech and biopharmaceutical professionals
- Endpoints News – Biotech and pharma business news, with a focus on the . . .
Biotech and pharma business news, with a focus on the science, people and money that drive the industry
- Clinical Trials - News, Articles etc. - European Pharmaceutical Review
Clinical Trials Show advanced filters news Dupixent receives first-in-decade EU approval in chronic spontaneous urticaria 25 November 2025 | By European Pharmaceutical Review European approval of Sanofi and Regeneron’s monoclonal antibody provides eligible urticaria patients with a new first-line targeted treatment option
- Pharma and Biotech News | The Pharmaletter
Pharma and Biotech NewsZhongmou Therapeutics, a Chinese genomic medicine company focused on restoring vision through gene and optogenetic therapies, has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to begin a multinational, randomized, single-masked, sham-controlled clinical trial (PRISM) of ZM-02 28 November 2025
- News - PharmaTimes
Bayer’s asundexian shows promise in landmark phase 3 stroke study 24th Nov 2025
- Recon: BioNTech, BMS tout positive Phase 2 readout for lung cancer; FDA . . .
Recon: BioNTech, BMS tout positive Phase 2 readout for lung cancer; FDA OKs trial of gene-edited pig kidneys for transplantation Recon | 08 September 2025 | Jason Scott Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing In Focus: US
|
|
|